144 related articles for article (PubMed ID: 16000844)
1. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis.
Ohike N; Morohoshi T
Endocr Pathol; 2005; 16(1):33-40. PubMed ID: 16000844
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors.
Hofer MD; Chang MC; Hirko KA; Rubin MA; Nosé V
Mod Pathol; 2009 Jul; 22(7):933-9. PubMed ID: 19377441
[TBL] [Abstract][Full Text] [Related]
3. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation.
Ohike N; Morohoshi T
Pathol Int; 2001 Oct; 51(10):770-7. PubMed ID: 11881729
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD
Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156
[TBL] [Abstract][Full Text] [Related]
7. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
La Rosa S; Klersy C; Uccella S; Dainese L; Albarello L; Sonzogni A; Doglioni C; Capella C; Solcia E
Hum Pathol; 2009 Jan; 40(1):30-40. PubMed ID: 18715612
[TBL] [Abstract][Full Text] [Related]
8. Mixed exocrine-endocrine tumors of the pancreas.
Klöppel G
Semin Diagn Pathol; 2000 May; 17(2):104-8. PubMed ID: 10839610
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of survivin in pancreatic endocrine tumors.
Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
11. KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers.
Zhang L; Smyrk TC; Oliveira AM; Lohse CM; Zhang S; Johnson MR; Lloyd RV
Am J Surg Pathol; 2009 Oct; 33(10):1562-9. PubMed ID: 19574886
[TBL] [Abstract][Full Text] [Related]
12. Multihormonality and entrapment of islets in pancreatic endocrine tumors.
Kapran Y; Bauersfeld J; Anlauf M; Sipos B; Klöppel G
Virchows Arch; 2006 Apr; 448(4):394-8. PubMed ID: 16418841
[TBL] [Abstract][Full Text] [Related]
13. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms.
Tomita T
Pathology; 2004 Dec; 36(6):566-70. PubMed ID: 15841692
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
Ali A; Serra S; Asa SL; Chetty R
Am J Surg Pathol; 2006 Dec; 30(12):1588-94. PubMed ID: 17122516
[TBL] [Abstract][Full Text] [Related]
16. Mixed ductal-endocrine carcinoma of the pancreas: a possible pathogenic mechanism for arrhythmogenic right ventricular cardiomyopathy.
Leteurtre E; Brami F; Kerr-Conte J; Quandalle P; Lecomte-Houcke M
Arch Pathol Lab Med; 2000 Feb; 124(2):284-6. PubMed ID: 10656740
[TBL] [Abstract][Full Text] [Related]
17. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic endocrine tumors with ductules.
Chetty R; Asa SL; Adsay NV
Am J Surg Pathol; 2005 Jan; 29(1):136-7; author reply 137-8. PubMed ID: 15613869
[No Abstract] [Full Text] [Related]
19. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
20. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas.
Matheus RS; Bernardi Fdel C; Gallo CP; da Silva AP; Rodrigues OR; Capelozzi M; Lopes A; Fenezelian S; Saldiva PH; Capelozzi VL
Pathol Res Pract; 2004; 200(1):13-23. PubMed ID: 15157046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
